Analyst Price Target is $6.00
▲ +191.26% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Perimeter Medical Imaging AI in the last 3 months. The average price target is $6.00, with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 191.26% upside from the last price of $2.06.
Current Consensus is
The current consensus among 1 contributing investment analysts is to buy stock in Perimeter Medical Imaging AI.
Perimeter Medical Imaging AI, Inc. is a medical technology company. It develops, patents, and commercializes surgical imaging tools. The firm's S-Series Optical Coherence Tomography Imaging System provides clinicians with cross-sectional and real-time margin visualization of an excised tissue specimen. It is also engaged in the development of its proprietary, next-gen ImgAssist, artificial intelligence technology under its ATLAS AI project. The company was founded by Elizabeth Munro, David Rempel, and Andrew Berkeley on May 16, 2013 and is headquartered in Toronto, Canada.